For the Inventor, By the Inventor

Enter assignee name

Raleigh, NC, United States of America

Sprout Pharmaceuticals, Inc.

USPTO Granted Patents = 15

% Expired Patents = 33.3

EPO Patents = 4

Trademarks = 2

Forward Citations = 48

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Angelo Ceci (6 out of 24 patents)

Kenneth Robert Evans (6 out of 8 patents)

Franco Borsini (6 out of 8 patents)

4. Marcus Schindler (5 out of 15 patents)

5. Vladimir Hanes (1 out of 3 patents)

6. Anna Elisabeth Verbeek (1 out of 2 patents)

7. Ramiro Castro (1 out of 2 patents)

8. Ralf Lotz (1 out of 16 patents)

9. Jaroslaw Mazurek (1 out of 2 patents)

10. Mihaela Pop (1 out of 4 patents)

11. Astrid Volz (1 out of 1 patent)

12. Fabio Paleari (1 out of 11 patents)

13. Enzo Cereda (24 patents)

14. Giovanni Battista Schiavi (8 patents)

15. Alessandro Brambilla (2 patents)

15 patents: Sort by Forward Citations

1. 11058683 - Treating sexual desire disorders with flibanserin (2021-07-13),

2. 10874668 - Use of Flibanserin in the treatment of obesity (2020-12-29),

3. 10675280 - Treating sexual desire disorders with flibanserin (2020-06-09),

4. 10596170 - Treatment of vasomotor symptoms (2020-03-24),

5. 10335407 - Use of flibanserin in the treatment of obesity (2019-07-02),

6. 10307420 - Treating sexual desire disorders with flibanserin (2019-06-04),

7. 9782403 - Treating sexual desire disorders with flibanserin (2017-10-10),

8. 9763936 - Flibanserin for the treatment of urinary incontinence and related diseases (2017-09-19),

9. 9730927 - Use of flibanserin in the treatment of obesity (2017-08-15),

10. 9546141 - Salts (2017-01-17),

11. 9468639 - Treating sexual desire disorders with flibanserin (2016-10-18),

12. 8785458 - Use of flibanserin in the treatment of obesity (2014-07-22),

13. 8722682 - Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity (2014-05-13),

14. 8227476 - Use of flibanserin in the treatment of obesity (2012-07-24),

15. 8227471 - Treating sexual desire disorders with flibanserin (2012-07-24),

Sprout Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development and commercialization of innovative therapies addressing unmet needs in women's health. With a focus on improving the quality of life for women, Sprout Pharmaceuticals is committed to researching, developing, and delivering safe and effective treatments. Through a combination of scientific expertise and dedication to patient advocacy, the company aims to empower women and provide them with the healthcare options they deserve.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

15 Patents

#55 in Raleigh, NC

#466 in North Carolina

#21,017 in US

#39,822 in the World

Raleigh, NC, United States of America

Sprout Pharmaceuticals, Inc.

Forward Citations = 48

12 inventors:

Angelo Ceci (6 out of 24 patents)

Kenneth Robert Evans (6 out of 8 patents)

Franco Borsini (6 out of 8 patents)

4. Marcus Schindler (5 out of 15 patents)

5. Vladimir Hanes (1 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…